StocksMedium•13 November 2026•
1 min read
vVardis Shares Slide 7% in NYSE Debut After IPO Prices Below Target Range
Key Facts
1Swiss dental startup vVardis saw its shares drop 7% during its New York Stock Exchange debut.
2The company sold 9.7 million shares at $18 each, falling short of its targeted range of $21 to $24 per share.
Swiss dental startup vVardis saw its shares drop 7% during its New York Stock Exchange debut on November 13, 2026. The New York Post reported that the company sold 9.7 million shares at $18 each, falling short of its targeted range of $21 to $24 per share.
The weak debut was attributed to a broader technology sector selloff that impacted the IPO market. These market conditions forced the company to price its shares at $18, significantly below the initial $21-$24 target range.